Skip to main content
VCbacked
Log inGet Started

Dualitas Therapeutics

San Francisco, United States

Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders

$65.0M raised
Sep 2025
Series A
Biotechnology

Top Investors

Eli LillySV Health InvestorsVersant VenturesQiming Venture Partners USAAlexandria Venture Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dualitas Therapeutics

How much funding has Dualitas Therapeutics raised?
Dualitas Therapeutics has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Who are Dualitas Therapeutics's investors?
Dualitas Therapeutics's investors include Eli Lilly, SV Health Investors, Versant Ventures, Qiming Venture Partners USA, Alexandria Venture Investments.
Where is Dualitas Therapeutics headquartered?
Dualitas Therapeutics is headquartered in San Francisco, United States.
What does Dualitas Therapeutics do?
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
What stage is Dualitas Therapeutics at?
Dualitas Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dualitas Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/dualitas-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Dualitas Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/dualitas-therapeutics
Wikipedia (cite web)
{{cite web |title=Dualitas Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dualitas-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong